
Climb Bio, Inc.: updates and filings
Price
$9.19
November 20, 2026Market cap $735M
What Ploutos Investor adds for Climb Bio
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
October 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 9, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Nov 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 5, 2026Shelf registration for future offeringsFormS-3ASR
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 28, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 27, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 26, 2026Regulation FD disclosure, other material eventsForm8-K
- Oct 23, 2026Regulation FD disclosure, other material eventsForm8-K
- Sep 3, 2026Regulation FD disclosureForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Other material eventsForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 8, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 7, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jul 1, 2026Officer or director changeForm8-K
- Jun 12, 2026Material agreement entered, other material eventsForm8-K
- Jun 11, 2026Other material eventsForm8-K
- Jun 9, 2026FilingFormEFFECT
- Jun 8, 2026Officer or director change, shareholder voteForm8-K
- Jun 5, 2026Correspondence with the SECFormCORRESP
- Jun 5, 2026Other material eventsForm8-K
- Jun 4, 2026Letter from the SECFormUPLOAD
- May 29, 2026Shelf registration for future offeringsFormS-3
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 9, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Nov 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 5, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 28, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 27, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 26, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Oct 23, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Sep 3, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | 8-K | Other material events | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 8, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 7, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jul 1, 2026 | 8-K | Officer or director change | Document |
| Jun 12, 2026 | 8-K | Material agreement entered, other material events | Document |
| Jun 11, 2026 | 8-K | Other material events | Document |
| Jun 9, 2026 | EFFECT | Filing | Document |
| Jun 8, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| Jun 5, 2026 | CORRESP | Correspondence with the SEC | Document |
| Jun 5, 2026 | 8-K | Other material events | Document |
| Jun 4, 2026 | UPLOAD | Letter from the SEC | Document |
| May 29, 2026 | S-3 | Shelf registration for future offerings | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 19, 2019.
The full analysis
What do Climb Bio's filings show?
The filings are where every one of Climb Bio's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.